Washing buffer solution for ion-exchange chromatography for preparation of FVIII (human coagulation factor VIII) and application of washing buffer solution

An ion exchange chromatography, washing buffer technology, applied in the direction of factor VII, coagulation/fibrinolysis factor, peptide preparation method, etc., can solve the problem that it is difficult to ensure that the visible foreign matter in the product is qualified, the preparation process of FVIII requires high, and the molecular weight of FVIII. It can achieve the effect of good industrial application prospects, good reconstitution performance and high activity yield.

Active Publication Date: 2016-04-13
CHENGDU RONGSHENG PHARMA
View PDF4 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] FⅧ has a large molecular weight, complex structure, and is easy to inactivate. Moreover, since it needs to be directly injected into the human body during use, the requirements for visible foreign matter in the product are strict, so the requirements for the preparation process of FⅧ are relatively high.
When using the existing process to prepare FⅧ, the activity loss is relatively large, especially after 72 hours of dry heat treat

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Washing buffer solution for ion-exchange chromatography for preparation of FVIII (human coagulation factor VIII) and application of washing buffer solution
  • Washing buffer solution for ion-exchange chromatography for preparation of FVIII (human coagulation factor VIII) and application of washing buffer solution

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046] Embodiment 1 Preparation of human blood coagulation factor VIII of the present invention

[0047] The preparation process of human coagulation factor VIII of the present invention is shown in figure 1 .

[0048] The preparation method is as follows:

[0049] Ⅰ. Pre-chromatographic treatment

[0050] (1) Using fresh frozen plasma as raw material, melt the plasma, centrifuge to prepare cryoprecipitate, dissolve the cryoprecipitate in 0.02M Tris buffer, precipitate with 30% polyethylene glycol, centrifuge after adsorption by aluminum hydroxide, and obtain the supernatant;

[0051] (2) After the supernatant was clarified and filtered at 0.45 μm, Tween-80 (polysorbate 80) and tributyl phosphate were added to make the final concentrations 1% and 0.3%, respectively, and treated at 25°C±1°C for 6 hours, and the process was completed. For the first virus inactivation (that is, SD virus inactivation), the sample must be loaded on the column.

[0052] Ⅱ. Ion exchange chromatog...

Embodiment 2

[0062] Embodiment 2 Preparation of human blood coagulation factor VIII of the present invention

[0063] The preparation method is as follows:

[0064] Ⅰ. Pre-chromatographic treatment

[0065] With embodiment 1.

[0066] Ⅱ. Ion exchange chromatography

[0067] (1) Prepare buffer

[0068] The balance buffer includes the following components: 0.01M sodium citrate, 0.001M calcium chloride, 0.121M glycine, 0.016M lysine hydrochloride, 0.06M sodium chloride; adjust pH to 6.5;

[0069] The washing buffer includes the following components: 0.01M sodium citrate, 0.001M calcium chloride, 0.121M glycine, 0.016M lysine hydrochloride, 0.121M sodium chloride; adjust pH to 6.5;

[0070] The elution buffer includes the following components: 0.01M sodium citrate, 0.001M calcium chloride, 0.121M glycine, 0.016M lysine hydrochloride, 0.25M sodium chloride; adjust pH to 6.5;

[0071] (2) Use ToyopearlDEAE650M as the gel for the chromatographic column filler; put the sample to be loaded on ...

Embodiment 3

[0075] Embodiment 3 Preparation of human blood coagulation factor VIII of the present invention

[0076] The preparation method is as follows:

[0077] Ⅰ. Pre-chromatographic treatment

[0078] With embodiment 1.

[0079] Ⅱ. Ion exchange chromatography

[0080] (1) Prepare buffer

[0081] Equilibrium buffer includes the following components: 0.01M sodium citrate, 0.001M calcium chloride, 0.121M glycine, 0.016M lysine hydrochloride, 0.16M sodium chloride; adjust pH to 7.5;

[0082] The washing buffer includes the following components: 0.01M sodium citrate, 0.001M calcium chloride, 0.121M glycine, 0.016M lysine hydrochloride, 0.129M sodium chloride; adjust pH to 7.5;

[0083] The elution buffer includes the following components: 0.01M sodium citrate, 0.001M calcium chloride, 0.121M glycine, 0.016M lysine hydrochloride, 0.35M sodium chloride; adjust pH to 7.5;

[0084] (2) Use ToyopearlDEAE650M as the gel for the chromatographic column filler; put the sample to be loaded on ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Specific activityaaaaaaaaaa
Specific activityaaaaaaaaaa
Specific activityaaaaaaaaaa
Login to view more

Abstract

The invention discloses a washing buffer solution for ion-exchange chromatography for preparation of an FVIII (human coagulation factor VIII). The washing buffer solution contains sodium chloride with the final concentration being 0.121-0.129 M. The invention further provides an application of the washing buffer solution. The invention further provides a method for preparing the FVIII and a prepared product. The washing buffer solution can better maintain the activity of the FVIII, the activity yield of the FVIII is high, the purity is high, the visible foreign matters are qualified, the stability is good, the formula of the washing buffer solution is simple, the cost is low, and the washing buffer solution has good industrial application prospect.

Description

technical field [0001] The invention belongs to the field of blood products, in particular to a washing buffer for ion exchange chromatography for preparing human blood coagulation factor VIII and its application. Background technique [0002] Human coagulation factor VIII (HumancoagulationfactorⅧ, FⅧ) is an important endogenous blood coagulation factor, FⅧ deficiency can lead to severe genetic bleeding disease - hemophilia A. Hemophilia A is the most common coagulation factor deficiency disease with the highest incidence rate. The most effective treatment method is to infuse the patient with plasma products rich in FⅧ to achieve the purpose of prevention and treatment. Therefore, FⅧ is a life-saving drug for patients with hemophilia A. [0003] FⅧ is made from healthy human plasma, which is separated, purified, virus-removed and inactivated, and freeze-dried. According to the 2015 edition of the Chinese Pharmacopoeia, the specific activity of human blood coagulation facto...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07K14/755C07K1/18
CPCC07K14/755
Inventor 牟蕾李伟鲁涛王黔川余伟
Owner CHENGDU RONGSHENG PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap